Mixed infection by Clostridium difficile in an in vitro model of the human gut

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

(2012) G. S. Crowther et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A pilot study of rapid benchtop sequencing ofStaphylococcus aureusandClostridium difficilefor outbreak detection and surveillance

(2012) David W Eyre et al.   BMJ Open

The economic burden of Clostridium difficile

(2011) S.M. McGlone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clostridium difficile Mixed Infection and Reinfection: Fig 1

(2011) David W. Eyre et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Coexistence of Multiple Multilocus Variable-Number Tandem-Repeat Analysis Subtypes ofClostridium difficilePCR Ribotype 027 Strains within Fecal Specimens

(2010) Hannah E. Tanner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection

(2009) S. D. Baines et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Use of Highly Discriminatory Fingerprinting to Analyze Clusters of Clostridium difficile Infection Cases Due to Epidemic Ribotype 027 Strains

(2008) W. N. Fawley et al.   JOURNAL OF CLINICAL MICROBIOLOGY